IE33016B1 - Concentrated liquid antacid compositions - Google Patents

Concentrated liquid antacid compositions

Info

Publication number
IE33016B1
IE33016B1 IE374/69A IE37469A IE33016B1 IE 33016 B1 IE33016 B1 IE 33016B1 IE 374/69 A IE374/69 A IE 374/69A IE 37469 A IE37469 A IE 37469A IE 33016 B1 IE33016 B1 IE 33016B1
Authority
IE
Ireland
Prior art keywords
phosphate
gluconate
calcium
april
sodium
Prior art date
Application number
IE374/69A
Other versions
IE33016L (en
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of IE33016L publication Critical patent/IE33016L/en
Publication of IE33016B1 publication Critical patent/IE33016B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1,200,157. Pharmaceutical vehicle; antacid composition. SMITH KLINE & FRENCH LABORATORIES. 1 April, 1969 [5 April, 1968], No. 17074/69. Heading A5B. An aqueous pharmaceutical vehicle comprises a combination of monobasic calcium phosphate and at least one of sodium, potassium, calcium or magnesium gluconate dissolved in water, wherein the phosphate and gluconate are each present in an amount from 0.5-7.0% W/V, provided that the total concentration of phosphate and gluconate is from 3-10% W/V. A liquid antacid composition comprises weight/volume of from 25-50% of solid antacid material suspended in an aqueous vehicle containing monobasic calcium phosphate and at least one of sodium, potassium calcium or magnesium gluconate. Conventional additives such as preservatives, flavours and solubilizers and anti-spasmodic agents or tranquilizers or glycine may also be present. [GB1200157A]
IE374/69A 1968-04-05 1969-03-21 Concentrated liquid antacid compositions IE33016B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71923468A 1968-04-05 1968-04-05

Publications (2)

Publication Number Publication Date
IE33016L IE33016L (en) 1969-10-05
IE33016B1 true IE33016B1 (en) 1974-02-20

Family

ID=24889291

Family Applications (1)

Application Number Title Priority Date Filing Date
IE374/69A IE33016B1 (en) 1968-04-05 1969-03-21 Concentrated liquid antacid compositions

Country Status (10)

Country Link
US (1) US3621094A (en)
AU (1) AU443154B2 (en)
BE (1) BE731060A (en)
DE (1) DE1915798C3 (en)
FR (1) FR2005599A1 (en)
GB (1) GB1200157A (en)
IE (1) IE33016B1 (en)
IL (1) IL31858A (en)
LU (1) LU58367A1 (en)
NL (1) NL6905135A (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1076479A (en) * 1976-09-17 1980-04-29 Lewis/Howe Company Concentrated magnesium hydroxide suspensions or emulsions and method for production thereof
JPS58192739U (en) * 1982-06-19 1983-12-21 仁川　春夫 Vehicle towing repair car
DE3343793A1 (en) * 1983-12-03 1985-08-01 Franz 8400 Regensburg Schöberl Towing-away device for motor vehicles
US4548817A (en) * 1984-01-20 1985-10-22 Webb-Waring Lung Institute Composition and method for treating mammalian acidosis
EP0215925A4 (en) * 1985-03-27 1987-10-26 Baxter Travenol Lab Supplemental calcium addition unit.
WO1986005981A1 (en) * 1985-04-18 1986-10-23 Borody Thomas J Treatment of non-ulcer dyspepsia with bismuth salts
US5762962A (en) * 1994-10-05 1998-06-09 Warner-Lambert Company Antacid pharmaceutical composition
EP0723452B1 (en) * 1993-10-13 2004-12-29 Warner-Lambert Company LLC Antacid pharmaceutical composition
US5455050A (en) * 1993-11-12 1995-10-03 Mcneil-Ppc, Inc. Aqueous antacids with calcium carbonate and magnesium salt
US5498426A (en) * 1994-10-03 1996-03-12 The Procter & Gamble Company Liquid antacid compositions
US20060257358A1 (en) * 2005-05-13 2006-11-16 Depuy Products, Inc. Suspension of calcium phosphate particulates for local delivery of therapeutic agents
CA2695504C (en) * 2007-08-03 2017-05-30 Nucitec S.A. De C.V. Compositions and methods for treatment and prevention of osteoarthritis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3062714A (en) * 1960-03-11 1962-11-06 Lewis Howe Company Antacid composition
US3215601A (en) * 1963-02-07 1965-11-02 Warner Lambert Pharmaceutical Antacid composition and method of making same
US3361769A (en) * 1964-01-22 1968-01-02 Synergistics Inc Bi-metallic salts of gluconic, glucuronic, or galacturonic acid
US3350266A (en) * 1964-06-04 1967-10-31 Bristol Myers Co Antacid composition comprising aluminum hydroxide, magnesium hydroxide and magnesium gluconate

Also Published As

Publication number Publication date
US3621094A (en) 1971-11-16
FR2005599A1 (en) 1969-12-12
NL6905135A (en) 1969-10-07
DE1915798A1 (en) 1969-11-06
BE731060A (en) 1969-10-06
AU443154B2 (en) 1973-11-28
IL31858A0 (en) 1969-05-28
IE33016L (en) 1969-10-05
FR2005599B1 (en) 1973-12-21
DE1915798C3 (en) 1978-04-27
LU58367A1 (en) 1970-11-09
DE1915798B2 (en) 1977-08-25
IL31858A (en) 1972-05-30
GB1200157A (en) 1970-07-29
AU5219669A (en) 1970-09-24

Similar Documents

Publication Publication Date Title
IE33016B1 (en) Concentrated liquid antacid compositions
GB1372008A (en) Water-in-oil emulsions
US3560380A (en) Dry concentrates for preparing hemodialysis solutions
SU513645A3 (en) Reagent for the determination of glucose
ES8600051A1 (en) Pharmaceutical composition
DE3067351D1 (en) Dentifrice with high foaming ability
GB1313645A (en) Flavouring process employing and compositions containing 3-phenyl pentenals
IL42313A (en) Pharmaceutical composition containing glycyrrhetinic acid for the treatment of oesophagitis
DE3478029D1 (en) Biopolymer compositions and process for their preparation
IE36510B1 (en) Anti-seborrhoeic compositions
IL37280A (en) Adenosine-5'-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
KR920008058A (en) Solid lactulose
GB1403900A (en) Pharmaceutical composition
DE2823824C2 (en)
IE34077L (en) Dentifrice compositions
IE34609B1 (en) Antineoplastic therapeutic compositions
GB1449146A (en) Prostaglandins and the preparation thereof
CA985702A (en) Polymers of 1-butene-2,3,4-tricarboxylic acid and their use as detergent builders
DE707256C (en) Process for preventing the corrosion of aluminum metal by ointment or paste-like masses
BE784373A (en) PROCESS AND COMPOSITIONS FOR THE PREPARATION OF NON-ALCOHOLIC BEVERAGES AND CONCENTRATES FOR SUCH BEVERAGES
GB1456264A (en) Method for preventing the formation of turbidity and/or deposits in non-alcoholic beverages containing saccharose and concentrates for such beverages
GB1396950A (en) Mustard paste
GB1353834A (en) Benzenesulphonamides
GB1201423A (en) Improvements in or relating to iron salt-antibiotic compositions
GB1253008A (en)